HIV/AIDS News

An investigational HIV vaccine was not successful at reducing the rate of HIV acquisition among a high-risk population group, according to data published in The New England Journal of Medicine.

Thousands of deaths from childhood tuberculosis could be prevented with $80 million per year, according to a press release.

Otolaryngologic conditions in pediatric patients with HIV have decreased in the post-antiretroviral era, recent data suggest.

Children with HIV who begin treatment early and are stable on ritonavir-boosted tipranavir regimens at week 48 appeared to remain stable up to 292 weeks after beginning treatment, recent data suggest.

The number of new HIV infections among adults and children declined by 33% since 2001, according to a new report issued by the Joint United Nations Programme on HIV/AIDS.

Despite implementation of a global plan to eliminate pediatric HIV, 210,000 new pediatric infections were added worldwide in 2012, and 230,000 children died of an AIDS-related illness in 2011, according to report data published in PLOS Medicine.

A CD4+ cell count of less than 50 cells/mcL before starting treatment is an independent risk factor for bone lost after initiation of antiretroviral therapy, according to study results published in Clinical Infectious Diseases.

Less overall antiretroviral therapy was seen when infants with HIV were treated with early time-limited antiretroviral therapy compared with deferred treatment, according to recent study findings published in The Lancet.

Antiretroviral drug regimens may protect against puberty delay in children with HIV, according to an NIH press release.

Vitamin D insufficiency and deficiency are common in children with HIV and children without HIV, according to recent study findings published in the Pediatric Infectious Disease Journal.